RARA CRAFT DATABASE for FDA Medical Devices
510(k)K250313

FDA DEVICE FACTS

Sterile Powder Free Synthetic Rubber Surgeon’s Gloves, Green Color, Tested For Use With Chemotherapy Drugs and Gastric Acid

Harps Europe Manufacturing GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 19, 2025PRODUCT CODEKGO

Indications for use

The Sterile Powder Free Synthetic Rubber Surgeon's Gloves, Green Color, Tested For Use With Chemotherapy Drugs and Gastric Acid is a single use disposable device intended to be worn by operating room personnel to protect a surgical wound from contamination. The tested drugs are: Compound Minimum Breakthrough Time (minutes) Carmustine (BCNU) (3.3 mg/ml) 15.8 Cyclophosphamide (20 mg/ml) >240 Doxorubicin (2 mg/ml) >240 Etoposide (Toposar) (20 mg/ml) >240 Fluorouracil (50 mg/ml) >240 Paclitaxel (6 mg/ml) >240 Thiotepa (THT) (10 mg/ml) 24.6 Bleomycin sulfate (15 mg/ml) >240 Carboplatin (10 mg/ml) >240 Cisplatin (1 mg/ml) >240 Cytarabine (100 mg/ml) >240 Dacarbazine (10 mg/ml) >240 Daunorubicin HCl (5 mg/ml) >240 Docetaxel (10 mg/ml) >240 Gemcitabine HCl (38 mg/ml) >240 Idarubicin HCl (1 mg/ml) >240 Ifosfamide (50 mg/ml) >240 Irinotecan HCl (20 mg/ml) >240 Mechlorethamine HCl (1 mg/ml) >240 Melphalan HCl (5 mg/ml) >240 Methotrexate (25 mg/ml) >240 Mitomycin C (0.5 mg/ml) >240 Mitoxantrone (2 mg/ml) >240 Vincristine Sulfate (1 mg/ml) >240 Busulfan (6 mg/ml) >240 Chloroquine (50 mg/ml) >240 Cyclosporin A (100 mg/ml) >240 Epirubicin HCl (2 mg/ml) >240 Fludarabine Phosphate (25 mg/ml) >240 Oxaliplatin (2 mg/ml) >240 Retrovir (10 mg/ml) >240 Rituximab (10 mg/ml) >240 Topotecan HCl (1 mg/ml) >240 Trisenox (Arsenic Trioxide) (1 mg/ml) >240 Velcade (Bortezomib) (1 mg/ml) >240 Simulated Gastric Acid Fluid was also tested with a minimum breakthrough greater than 240 minutes. WARNING: Please note the following drugs have extremely low permeation times: Carmustine: 15.8 minutes and Thiotepa: 24.6 minutes. Do not use with Carmustine and Thiotepa.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026